72 related articles for article (PubMed ID: 10094884)
21. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
Ma XX; Zhang SL; Gao S; Lu JM; Dong F
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
[TBL] [Abstract][Full Text] [Related]
22. Eosinophil-tumor cell interaction in advanced gastric carcinoma: an electron microscopic approach.
Caruso RA; Bersiga A; Rigoli L; Inferrera C
Anticancer Res; 2002; 22(6C):3833-6. PubMed ID: 12553002
[TBL] [Abstract][Full Text] [Related]
23. Characterization and phenotypic variation with passage number of cultured human endometrial adenocarcinoma cells.
Kato S; Espinoza N; Lange S; Villalón M; Cuello M; Owen GI
Tissue Cell; 2008 Apr; 40(2):95-102. PubMed ID: 18031781
[TBL] [Abstract][Full Text] [Related]
24. [Expression of cellular FLICE inhibitory protein (cFLIP) in endometrial adenocarcinoma].
Chen HX; Liu YJ; Li H; Wang ZS
Ai Zheng; 2004 Mar; 23(3):254-8. PubMed ID: 15025952
[TBL] [Abstract][Full Text] [Related]
25. Possible role of placental leucine aminopeptidase in the antiproliferative effect of oxytocin in human endometrial adenocarcinoma.
Suzuki Y; Shibata K; Kikkawa F; Kajiyama H; Ino K; Nomura S; Tsujimoto M; Mizutani S
Clin Cancer Res; 2003 Apr; 9(4):1528-34. PubMed ID: 12684429
[TBL] [Abstract][Full Text] [Related]
26. Expression of interferon-gamma-inducible protein 10 related to angiogenesis in uterine endometrial cancers.
Sato E; Fujimoto J; Tamaya T
Oncology; 2007; 73(3-4):246-51. PubMed ID: 18424889
[TBL] [Abstract][Full Text] [Related]
27. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
Fine BA; Valente PT; Feinstein GI; Dey T
Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
[TBL] [Abstract][Full Text] [Related]
28. Angiogenesis in endometrial cancer.
Mazurek A; Telego M; Pierzyñski P; Lapuć G; Nikliñska W; Juczewska M; Chyczewski L
Neoplasma; 1998; 45(6):360-4. PubMed ID: 10210108
[TBL] [Abstract][Full Text] [Related]
29. Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer.
Ribatti D; Finato N; Crivellato E; Marzullo A; Mangieri D; Nico B; Vacca A; Beltrami CA
Am J Obstet Gynecol; 2005 Dec; 193(6):1961-5. PubMed ID: 16325597
[TBL] [Abstract][Full Text] [Related]
30. Extracellular matrix-induced changes in expression of cell cycle-related proteins and proteasome components in endometrial adenocarcinoma cells.
Koistinen H; Seppälä M; Knuutila S; Koistinen R
Gynecol Oncol; 2006 Sep; 102(3):546-51. PubMed ID: 16497364
[TBL] [Abstract][Full Text] [Related]
31. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry.
Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W
Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685
[TBL] [Abstract][Full Text] [Related]
32. Activin A inhibits growth-inhibitory signals by TGF-beta1 in differentiated human endometrial adenocarcinoma cells.
Tanaka T; Toujima S; Umesaki N
Oncol Rep; 2004 Apr; 11(4):875-9. PubMed ID: 15010888
[TBL] [Abstract][Full Text] [Related]
33. Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma.
Leitao MM; Kehoe S; Barakat RR; Alektiar K; Gattoc LP; Rabbitt C; Chi DS; Soslow RA; Abu-Rustum NR
Gynecol Oncol; 2008 Nov; 111(2):244-8. PubMed ID: 18752842
[TBL] [Abstract][Full Text] [Related]
34. Expression of fos and jun proto-oncogenes in benign versus malignant human uterine tissue.
Nephew KP; Choi CM; Polek TC; McBride R; Bigsby RM; Khan SA; Husseinzadeh N
Gynecol Oncol; 2000 Mar; 76(3):388-96. PubMed ID: 10684716
[TBL] [Abstract][Full Text] [Related]
35. Impact of fibroblast growth factor-2 on tumor microvascular architecture. A tridimensional morphometric study.
Konerding MA; Fait E; Dimitropoulou C; Malkusch W; Ferri C; Giavazzi R; Coltrini D; Presta M
Am J Pathol; 1998 Jun; 152(6):1607-16. PubMed ID: 9626064
[TBL] [Abstract][Full Text] [Related]
36. Oxytocin receptors in human adenocarcinomas of the endometrium: presence and biological significance.
Cassoni P; Fulcheri E; Carcangiu ML; Stella A; Deaglio S; Bussolati G
J Pathol; 2000 Mar; 190(4):470-7. PubMed ID: 10699997
[TBL] [Abstract][Full Text] [Related]
37. The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium.
Sonoda K; Kaku T; Hirakawa T; Kobayashi H; Amada S; Sakai K; Nakashima M; Watanabe T; Nakano H
Gynecol Oncol; 2000 Dec; 79(3):424-9. PubMed ID: 11104614
[TBL] [Abstract][Full Text] [Related]
38. [Expression of matrix metalloproteinase-2, 9 and it's tissue inhibitor-1, 2 in endometrial carcinoma].
Guo W; Chen G; Zhu C; Wang H
Zhonghua Fu Chan Ke Za Zhi; 2002 Oct; 37(10):604-7. PubMed ID: 12487935
[TBL] [Abstract][Full Text] [Related]
39. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium.
Afify AM; Craig S; Paulino AF; Stern R
Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159
[TBL] [Abstract][Full Text] [Related]
40. Ultrastructural observations on inflammatory angiogenesis in gastric carcinomas with massive neutrophil infiltration.
Caruso RA; Bonanno A; Finocchiaro G; Cavaliere R; Gitto G; Plutino FM; Quattrocchi E; Cuppari MC; Fabiano V; Basile G
Ultrastruct Pathol; 2009; 33(1):1-5. PubMed ID: 19191195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
